Melissa M Hudson1, Wendy Leisenring2, Kayla K Stratton2, Nina Tinner2, Brenda D Steen2, Susan Ogg2, Linda Barnes2, Kevin C Oeffinger2, Leslie L Robison2, Cheryl L Cox2. 1. Melissa M. Hudson, Nina Tinner, Brenda D. Steen, Susan Ogg, Linda Barnes, Leslie L. Robison, and Cheryl L. Cox, St Jude Children's Research Hospital, Memphis, TN; Wendy Leisenring and Kayla K. Stratton, Fred Hutchinson Cancer Research Center, Seattle, WA; and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY. melissa.hudson@stjude.org. 2. Melissa M. Hudson, Nina Tinner, Brenda D. Steen, Susan Ogg, Linda Barnes, Leslie L. Robison, and Cheryl L. Cox, St Jude Children's Research Hospital, Memphis, TN; Wendy Leisenring and Kayla K. Stratton, Fred Hutchinson Cancer Research Center, Seattle, WA; and Kevin C. Oeffinger, Memorial Sloan Kettering Cancer Center, New York, NY.
Abstract
PURPOSE: To determine whether the addition of advanced-practice nurse (APN) telephone counseling to a printed survivorship care plan (SCP) significantly increases the proportion of at-risk survivors who complete cardiomyopathy screening. PATIENTS AND METHODS: Survivors age ≥ 25 years participating in the Childhood Cancer Survivor Study who received cardiotoxic therapy and reported no history of cardiomyopathy screening in the previous 5 years were eligible for enrollment. The 472 participants (mean age, 40.1 years; range, 25.0 to 59.0; 53.3% women) were randomly assigned to either standard care, consisting of an SCP summarizing cancer treatment and cardiac health screening recommendations (n = 234), or standard care plus two APN telephone counseling sessions (n = 238). The primary outcome-completion of cardiomyopathy screening within 1 year-was validated by medical records and compared between the two arms using adjusted relative risks (RRs) with 95% CIs. RESULTS: Participants in the standard and APN counseling groups were not statistically different by demographic or clinical characteristics. At the time of 1-year follow-up, 107 (52.2%) of 205 survivors in the APN group completed screening compared with 46 (22.3%) of 206 survivors in the non-APN group (P < .001). With adjustment for sex, age (< 30 v ≥ 30 years), and Children's Oncology Group-recommended screening frequency group (annual, 2 years, or 5 years), survivors in the APN group were > 2× more likely than those in the control group to complete the recommended cardiomyopathy screening (RR, 2.31; 95% CI, 1.74 to 3.07). CONCLUSION: The addition of telephone counseling to an SCP with cardiac health screening recommendations increases cardiomyopathy screening in at-risk survivors.
RCT Entities:
PURPOSE: To determine whether the addition of advanced-practice nurse (APN) telephone counseling to a printed survivorship care plan (SCP) significantly increases the proportion of at-risk survivors who complete cardiomyopathy screening. PATIENTS AND METHODS: Survivors age ≥ 25 years participating in the Childhood Cancer Survivor Study who received cardiotoxic therapy and reported no history of cardiomyopathy screening in the previous 5 years were eligible for enrollment. The 472 participants (mean age, 40.1 years; range, 25.0 to 59.0; 53.3% women) were randomly assigned to either standard care, consisting of an SCP summarizing cancer treatment and cardiac health screening recommendations (n = 234), or standard care plus two APN telephone counseling sessions (n = 238). The primary outcome-completion of cardiomyopathy screening within 1 year-was validated by medical records and compared between the two arms using adjusted relative risks (RRs) with 95% CIs. RESULTS:Participants in the standard and APN counseling groups were not statistically different by demographic or clinical characteristics. At the time of 1-year follow-up, 107 (52.2%) of 205 survivors in the APN group completed screening compared with 46 (22.3%) of 206 survivors in the non-APN group (P < .001). With adjustment for sex, age (< 30 v ≥ 30 years), and Children's Oncology Group-recommended screening frequency group (annual, 2 years, or 5 years), survivors in the APN group were > 2× more likely than those in the control group to complete the recommended cardiomyopathy screening (RR, 2.31; 95% CI, 1.74 to 3.07). CONCLUSION: The addition of telephone counseling to an SCP with cardiac health screening recommendations increases cardiomyopathy screening in at-risk survivors.
Authors: Gregory T Armstrong; Toana Kawashima; Wendy Leisenring; Kayla Stratton; Marilyn Stovall; Melissa M Hudson; Charles A Sklar; Leslie L Robison; Kevin C Oeffinger Journal: J Clin Oncol Date: 2014-03-17 Impact factor: 44.544
Authors: Steven E Lipshultz; Stuart R Lipsitz; Stephen E Sallan; Virginia M Dalton; Suzanne M Mone; Richard D Gelber; Steven D Colan Journal: J Clin Oncol Date: 2005-04-20 Impact factor: 44.544
Authors: Elvira C van Dalen; Helena J H van der Pal; Wouter E M Kok; Huib N Caron; Leontien C M Kremer Journal: Eur J Cancer Date: 2006-09-20 Impact factor: 9.162
Authors: Helena J H van der Pal; Elvira C van Dalen; Leontien C M Kremer; Piet J M Bakker; Flora E van Leeuwen Journal: Cancer Treat Rev Date: 2005-05 Impact factor: 12.111
Authors: Kevin C Oeffinger; Ann C Mertens; Charles A Sklar; Toana Kawashima; Melissa M Hudson; Anna T Meadows; Debra L Friedman; Neyssa Marina; Wendy Hobbie; Nina S Kadan-Lottick; Cindy L Schwartz; Wendy Leisenring; Leslie L Robison Journal: N Engl J Med Date: 2006-10-12 Impact factor: 176.079
Authors: Leslie L Robison; Ann C Mertens; John D Boice; Norman E Breslow; Sarah S Donaldson; Daniel M Green; Frederic P Li; Anna T Meadows; John J Mulvihill; Joseph P Neglia; Mark E Nesbit; Roger J Packer; John D Potter; Charles A Sklar; Malcolm A Smith; Marilyn Stovall; Louise C Strong; Yutaka Yasui; Lonnie K Zeltzer Journal: Med Pediatr Oncol Date: 2002-04
Authors: F Pein; O Sakiroglu; M Dahan; J Lebidois; P Merlet; A Shamsaldin; E Villain; F de Vathaire; D Sidi; O Hartmann Journal: Br J Cancer Date: 2004-07-05 Impact factor: 7.640
Authors: Emily S Tonorezos; Melissa M Hudson; Angela B Edgar; Leontien C Kremer; Charles A Sklar; W Hamish B Wallace; Kevin C Oeffinger Journal: Lancet Diabetes Endocrinol Date: 2015-04-12 Impact factor: 32.069
Authors: Eric J Chow; Kasey J Leger; Neel S Bhatt; Daniel A Mulrooney; Colin J Ross; Sanjeev Aggarwal; Neha Bansal; Matthew J Ehrhardt; Saro H Armenian; Jessica M Scott; Borah Hong Journal: Cardiovasc Res Date: 2019-04-15 Impact factor: 10.787
Authors: Kristin C Marr; Mohammad Agha; Rinku Sutradhar; Jason D Pole; David Hodgson; Astrid Guttmann; Mark Greenberg; Paul C Nathan Journal: J Cancer Surviv Date: 2017-08-07 Impact factor: 4.442
Authors: Shaylyn S Stark; Loki Natarajan; Diana Chingos; Jennifer Ehren; Jessica R Gorman; Michael Krychman; Brian Kwan; Jun J Mao; Emily Myers; Tom Walpole; John P Pierce; H Irene Su Journal: Contemp Clin Trials Date: 2018-12-12 Impact factor: 2.226
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Rebecca E Hill; Claire E Wakefield; Richard J Cohn; Joanna E Fardell; Mary-Ellen E Brierley; Emily Kothe; Paul B Jacobsen; Kate Hetherington; Rebecca Mercieca-Bebber Journal: Oncologist Date: 2019-10-25
Authors: Stephanie B Dixon; Eric J Chow; Lars Hjorth; Melissa M Hudson; Leontien C M Kremer; Lindsay M Morton; Paul C Nathan; Kirsten K Ness; Kevin C Oeffinger; Gregory T Armstrong Journal: Pediatr Clin North Am Date: 2020-12 Impact factor: 3.278
Authors: Saro H Armenian; Gregory T Armstrong; Gregory Aune; Eric J Chow; Matthew J Ehrhardt; Bonnie Ky; Javid Moslehi; Daniel A Mulrooney; Paul C Nathan; Thomas D Ryan; Helena J van der Pal; Elvira C van Dalen; Leontien C M Kremer Journal: J Clin Oncol Date: 2018-06-06 Impact factor: 44.544
Authors: H Irene Su; Shaylyn Stark; Brian Kwan; Sarah Boles; Diana Chingos; Jennifer Ehren; Jessica R Gorman; Michael Krychman; Sally A D Romero; Jun J Mao; John P Pierce; Loki Natarajan Journal: Breast Cancer Res Treat Date: 2019-05-03 Impact factor: 4.872
Authors: Eric J Chow; Kirsten K Ness; Gregory T Armstrong; Nickhill Bhakta; Jennifer M Yeh; Smita Bhatia; Wendy Landier; Louis S Constine; Melissa M Hudson; Paul C Nathan Journal: Semin Oncol Date: 2020-03-04 Impact factor: 4.929